Dashboard
Manage Tickers

ELDN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

eledon-pharmaceuticals-launches-50m-offering-of-152m-common-shares-at-165share-152m-warrants-at-1649warrant
Eledon Pharmaceuticals Launches ~$50M Offe...
11/12/2025 12:59:58

Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ: ELDN), today announced the pricing of its underwritten public offering...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
11/12/2025 12:05:51

eledon-pharmaceuticals-reveals-proposed-underwritten-public-offering-of-common-stock-and-pre-funded-warrants-size-not-disclosed
Eledon Pharmaceuticals Reveals Proposed Un...
11/11/2025 22:28:29

Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN), today announced that it has commenced an underwritten public off...

eledon-pharmaceuticals-lead-asset-fails-in-mid-stage-study-but-pushes-forward-with-pivotal-study
Eledon Pharmaceuticals' Lead Asset Fails I...
11/07/2025 18:36:22

Eledon shares drop as tegoprubart misses the main goal in Phase 2 kidney transplant trial, though safety signals and kidney fun...

dow-dips-over-200-points-fluor-shares-slide-after-q3-results
Dow Dips Over 200 Points; Fluor Shares Sli...
11/07/2025 18:28:24

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
11/07/2025 17:05:53

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
11/07/2025 12:05:44

eledon-pharmaceuticals-phase-2-bestow-trial-shows-tegoprubart-maintains-strong-kidney-function-and-safety-supporting-phase-3-advancement-in-transplant-rejection-prevention
Eledon Pharmaceuticals' Phase 2 BESTOW Tri...
11/06/2025 23:33:34

Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular ...

eledon-pharmaceuticals-to-present-phase-2-bestow-topline-results-of-tegoprubart-in-kidney-transplant-at-asn-kidney-week-2025-on-nov-6
Eledon Pharmaceuticals To Present Phase 2 ...
10/17/2025 11:03:51

hc-wainwright--co-reiterates-buy-on-eledon-pharmaceuticals-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
09/02/2025 11:05:30

HC Wainwright & Co. analyst Yi Chen reiterates Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy and maintains $9 price ta...

eledon-pharma-q2-eps-013-beats-024-estimate
Eledon Pharma Q2 EPS $(0.13) Beats $(0.24)...
08/14/2025 20:45:02

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.24)...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/07/2025 17:09:32

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/07/2025 12:07:31

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/06/2025 21:07:28

voyager-eledon-presents-data-from-phase-1b-trial-evaluating-tegoprubart-for-prevention-of-rejection-in-kidney-transplant-patients
Voyager Eledon Presents Data From Phase 1b...
08/06/2025 20:54:31

Data from patients who remained on tegoprubart for a year showed overall mean 12-month eGFR of approximately 68 mL/min/1.73 m² ...

eledon-pharmaceutical-to-host-a-conference-call-and-webcast-on-wednesday-august-6-2025-to-discuss-updated-clinical-data-from-its-ongoing-open-label-phase-1b-study-evaluating-tegoprubart-for-the-prevention-of-rejection-in-subjects-undergoing-kidney-transplantation
Eledon Pharmaceutical To Host A Conference...
07/30/2025 20:30:50

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN) today announced...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
07/28/2025 21:05:57

craig-hallum-initiates-coverage-on-eledon-pharmaceuticals-with-buy-rating-announces-price-target-of-12
Craig-Hallum Initiates Coverage On Eledon ...
07/25/2025 17:54:47

Craig-Hallum initiates coverage on Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy rating and announces Price Target of $12.

eledon-pharma-to-present-updated-clinical-data-from-ongoing-open-label-phase-1b-study-evaluating-tegoprubart-for-prevention-of-rejection-in-subjects-undergoing-kidney-transplantation-at-wtc-2025
Eledon Pharma To Present Updated Clinical ...
07/17/2025 20:03:14

Core News & Articles
Eledon And Sernova Collaborate To Test Teg...
07/09/2025 12:36:02

Sernova Biotherapeutics ("Sernova") (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research A...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION